Sign in

Registered Nurse Home Health

Germantown, MD
June 30, 2020

Contact this candidate



***** ********* **** **********, ** 20874

Cell: 815-***-****


A Registered Nurse experienced in working with in-patient and outpatient care providers in a team setting consisting of physicians, nurses, physical therapists, occupational therapists, speech therapists and pharmacists, and in the development and purification of cGMP compliant Biopharmaceuticals for preclinical and clinical studies including marketed products. Looking forward to using my professional skills as a Clinical Research



BSN: June 2020

American Sentinel University

Registered Nurse: R218345 August 2015

Associate of Arts in Nursing (ADN) with Honors: May 2015

Howard Community College, Columbia, MD

Ph.D., Physiology: December 1986

University of Manchester, Manchester, UK

B.Sc. Biology (Minor: Chemistry): May 1981 University of Asmara, Asmara, Eritrea


Nurse Monitor 2015 – Present


(Contractor: for the Department of Health and Human Services)

Administer and complete comprehensive health care assessments to eligible clients in their homes as ordered on the individualized Registered Nurse Monitoring plans of care and monitor each client's health, condition, and safety while providing quality oversight of provider services.

This included:

Assessing eligible individuals and completing the assessment tool.

Handling and managing assigned caseloads of eligible individuals, making timely contacts, and providing feedback to all parties as required.

Providing quality oversight of providers in the homes of eligible individuals.

Monitoring clients’ medications when needed.

Liaising with PCPs, families, supports planners, and County health workers.

Reporting to Potomac Health Services, support planners, and the County staff any incidents/observations of unusual nature (such as a Reportable Event situation)

Loading assessment information into a Long-Term Services and Supports (LTSS) database within 48 hours of completion of the assessment.

RN Case Manager Mar 2018- April 2020


Provided, coordinated, and direct the provision of home nursing care according to physician's orders based on agency policies and procedures using the nursing practice

Visited patients, reviewed and reconciled medications, assessed and evaluated patients’ progress, supervised LPNs, and Home Health Associates

Educated and then obtained informed consent from patients

Performed patient comprehensive assessments and collaborated with patients’ multi-disciplinary care team consisting of Physical Therapists, Occupational Therapists, Speech Therapists, Medical Social Workers, and other health care professionals to develop/modify/implement an individualized plan of care per physician orders to ensure quality, proper discharge planning, and desired outcomes and goals.

Helped to achieve and maintain continuity of patient care by communicating information (for example, changes in the plan of care, new orders, lab results, etc.) timely, effectively, and systematically with all team members providing care to the patient

Facilitated interdisciplinary communication, feedback, and follow-up through care coordination on assigned patients and/or caseloads of patients for the duration they are on service

Regularly attended weekly team meetings, update team, and upper management on relevant patient progress and management

Recommended and make referrals to other disciplines as indicated by the patient's needs or document rationale for not doing so

Utilized a combination of care center resources and recognized standards of practice to achieve positive clinical outcomes

Participated in clinical outcomes monitoring, follow-up on care center performance improvement initiatives.

Initiated, planned, and provided staff education as needed

Utilized accepted company teaching materials for patient/family/significant other education

Reported and complete reporting of adverse events accurately and timely manner

Documented findings on time and accurately at the point of care, according to industry standards, and guidelines, including Outcome and Assessment Information Set (OASIS), Start of Care (SOC)/Admissions, Recertifications, Advance Beneficiary Notice of Noncoverage (ABNs), subsequent visits, physician orders, care coordination

Critical Care Nurse II Telemetry, Med/Surg, Neuro/Stroke Unit Sept. – Dec. 2017


Performed admission assessment of patients.

Prepared patients for stress testing, echocardiograms, peripheral diagnostic studies, cardiac catheterization procedures, and the operation room.

Received patient's from Catherization lab and performed an appropriate assessment for vital signs, affected limb, insertion site, and restriction in activity immediately after the procedure.

Prepared and administered oral, rectal, NG/PEG tubes, SUBQ, IM, IV, recorded prescribed medications, and evaluated patient's response to clinical intervention and progress toward goals.

Monitored patients with cardiac conditions such as chest pains, arrhythmias, CVA, MI, post-infarct, and identified heart rhythms such as a-Fib, heart blocks, v-Tach/Fib and reported to the physician for clinical treatment.

Participated in a multidisciplinary team of medical professionals to assess, evaluate, and diagnose patients and develop effective treatment plans under the direction of the physician

Acted as a patient advocate; interacted in a timely manner between multidisciplinary staff to minimize delays and optimize patient care and efficiency.

Modified and individualized nursing care according to the patient, family, and significant other based on the culture, demographics, history, needs, and provided patient, family, and significant others education in disease states, expectations, medications, and home health care.

Documented through electronic notes regarding patient care and status during shift.

Coordinated patient discharge plans with the healthcare team and provided patient, family, and significant others guidance and support in illness management, medication, and side effects, diet, nutrition, exercise, and follow-up appointments.

Managed and provided clinical direction to CNAs.

Registered Charge Nurse, Rehab- Med/Surg Sept. 2015 to May 2017


Supervised all nursing activities on the assigned unit

Observed and evaluated residents’ physical and emotional status

Administered oral, rectal, Nasogastric/ percutaneous endoscopy gastrostomy tubes, subcutaneous, intramuscular, intravenous medications

Treated wounds per physician order, evaluate and reported wound healing progress

Reviewed medication records and clinical intervention records for completeness of

information, accuracy in the transcription of physician orders, and effectiveness of medications, and/or treatment

Reviewed lab results and informed patients and designated family members/significant others

For admissions, discharge, and transfer of patients from one unit to the other, completed required documentation using the electronic medical record system

Assured the client’s plan of care was being followed

Effectively delegated responsibilities for the direct care of specific residents

Arranged schedule to allow time for supervision and evaluation of performance of all nursing personnel on the unit

Kept the Nurse Manager informed on the status of residents and other related matters through written reports and verbal communication

Provided direct resident care as needed

Collaborated with social workers, physical/occupational therapists, dieticians, and quality control


Scientist (Contractor) August–October 2011

MEDIMMUNE – Frederick, Maryland

Qualified downscale model chromatography steps (affinity, anion exchange, and cation exchange) and viral filtration step for the purification of recombinant monoclonal antibodies for clinical use

Enabled the CMO to transfer the downscale model to manufacturing scale to produce product for Phase III clinical trials

Diploma (in ICH, GMP, GLP and GCP Guidelines) Dec. 2008–May 2009


Training in:

Quality assurance, GMP, GCP, and GLP; processing operations, in-process control, statistical quality control, control of pharmaceutical products including product testing, experimental techniques and technical documentation, knowledge of ICH GCP guidelines training for laboratory and manufacturing environment, application of GMP, ICH, FDA and TPD guidelines relative to quality issues, generating audit and non-conformance reports for in-line and in-process tests in both manufacturing and laboratory settings; preparation of protocols, SOP's, and other technical documents in accordance to in-house, compendial and regulatory requirements

Internship with KRC Inc.:

Prepared the audits of the QC lab with a primary focus on reviewing laboratory records.

Generated a raw material specification and a finished product specification for Product rhEGF for the USA

Prepared testing and limits meeting the requirements of the USP monographs.

Wrote sampling documents specifying the amounts of raw material and finished products required to conduct full testing.

Compiled concise report outlining the submission requirements,

Wrote a detailed SOP detailing the use of specific manufacturing equipment and laboratory apparatus.

Created a flow chart outlining the processes and critical controls involved in a pharmaceutical environment from the time raw materials are received, to the manufacture of the product, and the shipping of the finished packaged product to consumers for use and applied the GMP, GLP and GCP regulations in the activities listed above.

Scientist II Dec. 2004 – Dec. 2007

PDL BIOPHARMA – Brooklyn Park, Minnesota

Involved in manufacturing process steps of biotechnology derived monoclonal

antibody products for Crohn’s disease from cell culture clarification to formulation

Wrote/reviewed technical reports for products clinical manufacturing campaign

AVENTIS BEHRING – Bradley, Illinois Jul. 1995 – Jun. 2004

Manager, Plasma Derived Coagulation Products 2002 – 2004

Implemented manufacturing process improvement protocols to increase product quality and yield.

Lead the reformulation efforts to reduce the polymer content of marketed coagulation products.

Facilitated and participated in meetings with upper management, collaborators, and quality assurance auditors

Reviewed manufacturing protocols and operating procedures

Member of corrective and preventive action plans (CAPA) including for manufacturing deviation

Research Scientist / Senior Development Scientist March 1997 – March 2002

Qualified product intermediates to be shipped and manufactured at different sites.

Developed and qualified scaled-down models for chromatographic process steps.

Collected and analyzed purification process data and wrote protocols, reports, and presented results to upper management.

Postdoctoral Fellow July 1995 – March 1997

Developed and established in-vivo animal model studies to evaluate the efficacy of products in development.

Reviewed Pharmacology and Toxicology supporting protocols, collected data, and final reports for Investigational New Drug (IND) submission.

Reviewed Pharmacology and Toxicology supporting protocols, collected data, and reports for studies performed by contract laboratories.


Research Scientist Nov. 1992 – Jun. 1995

University of Chicago, Chicago IL

Established an in-vitro model for maternal-fetal transfer studies across the

perfused human placenta

Postdoctoral Fellow Nov. 1986 – Dec. 1988

University of Cincinnati, Cincinnati, OH

• Established and in-vitro model for the maternal-fetal effect of serotonin, angiotensin II, prostaglandins and thromboxane on the perfused human placenta


Adjunct Professor – Chemistry Spring 2013

Howard Community College, Columbia, MD

Adjunct Professor – Biology Fall 2009 - Spring 2011

Montgomery College, Germantown, MD


•Howard Community College Dean List, Columbia, Maryland, USA

•Nestle Nutrition Research Program, University of Manchester, United Kingdom

•ORS (Overseas Research Student) Award, University of Manchester, United Kingdom

•University of Asmara Fellowship (U.N.D.P.), University of Asmara, Eritrea


Kahsai, T.Z., Roth, N.J., Zhao, Y., Gallagher, C.N., Boreisha, I., Berhe, A., Read, M. Taylor, K., Bode, A., Blajchman, M., Balshuweit, G., Brown, L., Summaria, L.J., Huang, C.C., Flanigan, E., and Feldman, F. (1995). Development of a pilot scale protocol for the preparation of lyophilized human platelets that retain physiological integrity and hemostatic functionality. Blood, J. of American Society of Hematology, Vol. 86, (No. 10) Supplement 1. No. 1406.

Berhe, A., Smith, T., Clark, K., and Myatt, L. (1989). The effect of calcium concentration on vascular reactivity in the perfused human placental cotyledon. Society for Gynecological Investigation.

Berhe, A., Harkes, A., and Sibley, C.P. (1988). Effects of histamine on vascular resistance and protein permeability in the isolated dually perfused guinea pig placenta. J. Dev. Physiol. 10:357-69.

Myatt, L., Berhe, A., Guilitto, R., and Brockman, D. (1988). The relationship of perfusion pressure to eicosanoid production in the human placental cotyledon. 6th International Congress of International Society for the Study of Hypertension in Pregnancy. Montreal, May 22-26.

Berhe, A., Bardsley, W.G., Harkes, A., and Sibley, C.P. (1987). Molecular charge effects on the protein permeability of the guinea pig placenta. Placenta 8: 365-380.

Berhe, A., Harkes, A., and Sibley, C.P. (1987). Microvascular effects of histamine in the dually perfused guinea pig placenta. J. Physiol. 387:70P.

Berhe, A., Harkes, A., and Sibley, C.P. (1986). Differential effects of histamine on the permeability of the dually perfused guinea pig placental to anionic and cationic HRP. Placenta 7:460.

Sibley, C.P., Berhe, A., and Harkes, A. (1986). Histamine affects the protein permeability of the dually perfused guinea pig placenta. I.U.P.S. Congress Proceedings p.99.

Berhe, A., Harkes, A., and Sibley, C.P. (1985). Effect of molecular charge on guinea pig placental permeability; Quantitative measurement using horseradish peroxidase (HRP). J. Physiol. 369: 155p.

Berhe, A., Harkes, A., Sibley, C.P. (1984). Quantitative measurement of placental protein permeability. European Placental Group


L. J. Summaria, A. Berhe, N. Roth, M. Even. Method for preparing a diafiltered stabilized blood product. PCT Int. App> WO ((55,346 (Cl.A61K35/14), 4 Nov. 1999, US Appl.66, 694, 27 Apr 1998; 38pp. In CA Selects: Formulation Chemistry. Issue 25, p 14, 1999.

Contact this candidate